Kevin Durant Will Wait To Sign New Deal With Warriors

While Kevin Durant is a lock to return to the Warriors, he doesn’t intend to finalize a new deal with the team when free agency opens on July 1, reports ESPN’s Marc Stein. According to Stein, Durant’s plan is to wait until after Golden State has conducted most of its offseason business to re-sign with the team.

Sources tell Stein that Durant has made it clear he won’t meet with other teams or field rival offers from potential suitors, so it’s a matter of when – not if – he officially signs a new deal with the Warriors. One of Stein’s sources suggests it may not happen until “later” in July, though if Golden State wraps up most of its other major moves shortly after the moratorium ends, Durant would likely have no reason to wait beyond mid-July.

Durant, who turned down a player option for 2017/18, is eligible for a starting salary worth up to $34.65MM based on a $99MM cap. However, he’s expected to accept a slightly more modest raise in order to allow the Warriors to attempt to sign Andre Iguodala and/or Shaun Livingston. By signing Durant to a raise using his Non-Bird rights, the Warriors would retain full Bird rights on Iguodala and Livingston, allowing the team to make competitive offers to those key role players.

[RELATED: Iguodala receiving interest from at least seven teams; Livingston could command $10-12MM annually]

Of course, just because the Warriors have Bird rights on Iguodala and Livingston, that doesn’t guarantee they’ll return. If a rival team makes a lucrative multiyear offer that the Warriors aren’t comfortable matching, it’s possible Iguodala and/or Livingston will head elsewhere rather than accepting a “hometown” discount to remain with the defending champions.

If the Warriors were to lose Iguodala and Livingston, waiting to sign his new contract could allow Durant to potentially earn the full max after all, since the club would be able to renounce its rights to its other free agents and create cap room to accommodate Durant.

View Comments (8)